The newly notified regulations seek to:
Ensure fair compensation to local communities and biodiversity conservers.
Boost corporate compliance, especially in high-usage sectors like pharmaceuticals, food, cosmetics, and AYUSH.
Expand the scope of benefit-sharing to cover Digital Sequence Information (DSI), aligning India with international biodiversity governance norms.
For economically or ecologically sensitive species such as sandalwood, red sanders, and agarwood, a higher benefit-sharing threshold has been set:
Certain categories have been exempted to streamline compliance and encourage sustainable practices:
Products based entirely on cultivated medicinal plants.
Specific mixed-source AYUSH products, as notified by the Ministry of Environment, Forest and Climate Change (MoEFCC) and Ministry of AYUSH.
In a significant policy evolution, the regulations include Digital Sequence Information (DSI) in the benefit-sharing mandate which was not a part of 2014 guidelines. This marks India's compliance with the emerging global frameworks that aligns with the outcomes from Nagoya Protocol under Convention on Biological Diversity (CBD) and COP16.
Financial Impact
● Highlights that benefit-sharing payments will be determined based on turnover and the extent of commercial utilization. ● Clarifies that users who have obtained approval must share benefits, excluding government taxes, making it a direct financial obligation.
Legal Risk
● Notes penalties of up to ₹50 lakh for non-compliance under the Biological Diversity Act. ● Discusses legal enforceability and the role of NBA in ensuring compliance and legal proceedings in case of violation.
Operational Burden
● Emphasizes new procedural approvals, monitoring mechanisms, and mandatory reporting for users of biological resources. ● Details new compliance steps including documentation, benefit-sharing agreements, and submission of periodic reports.
Reputational Risk
● Notes that transparency in biodiversity usage and benefit-sharing is critical to avoid public and regulatory scrutiny. ● Points to increased attention on misuse or greenwashing related to biodiversity claims.
Strategic Opportunity
● Highlights how proactive compliance supports international alignment, especially with the Nagoya Protocol. ● States that benefit-sharing fosters trust with local communities and biodiversity conservers, supporting ESG goals.
Conduct resource audits to track biological material usage.
Consult the NBA and State Biodiversity Boards (SBBs) for approvals and clarifications.
Integrate compliance into ESG frameworks, procurement, and R&D pipelines.
Access and Benefit Sharing (ABS) policies of the Centre establish uniform norms for equitable utilization of India's biological resources. Uniform norms bring industrial progress together with environmental protection through procedural methods that harmonize industrial activity with conservation objectives. The standardized benefit-sharing approach introduces ethical and structured resource use, particularly benefiting pharmaceutical and biotechnology sectors. The long-term effectiveness of such regulations depends on strong enforcement and efficient monitoring systems. In the future, Indian policymakers will have to continuously modify regulatory systems, while promoting worker involvement in ecological practices. Such coordination will bring about a sustainable balance between economic development and scientific progress, reinforcing India's dedication to innovation and environmental care.
